128 related articles for article (PubMed ID: 1973719)
61. Adhesion molecules from the LFA-1/ICAM-1,3 and VLA-4/VCAM-1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands.
Marazuela M; Postigo AA; Acevedo A; Díaz-González F; Sanchez-Madrid F; de Landázuri MO
Eur J Immunol; 1994 Oct; 24(10):2483-90. PubMed ID: 7523142
[TBL] [Abstract][Full Text] [Related]
62. Immune complex deposits in thyroid glands of patients with Graves' disease. II. Anti-thyroglobulin and anti-microsome activities of gamma-globulin eluted from thyroid homogenates.
Fujiwara H; Torisu M; Sugisaki T; Okano H
Clin Immunol Immunopathol; 1981 Apr; 19(1):109-17. PubMed ID: 6163581
[No Abstract] [Full Text] [Related]
63. The expression of adhesion molecules in thyroid glands from patients with Graves' disease.
Nakashima M; Eguchi K; Ida H; Yamashita I; Sakai M; Origuchi T; Kawabe Y; Ishikawa N; Ito K; Nagataki S
Thyroid; 1994; 4(1):19-25. PubMed ID: 7519914
[TBL] [Abstract][Full Text] [Related]
64. B- and T-lymphocytes in toxic diffuse goitre.
Sköldstam L; Anderberg B; Norrby K
Clin Exp Immunol; 1978 Mar; 31(3):524-5. PubMed ID: 350461
[TBL] [Abstract][Full Text] [Related]
65. IFN-gamma has a protective role against thyroid-specific autoantibody production in severe combined immunodeficient (SCID) mice xenografted with Graves' thyroid tissue.
Yoshikawa N; Mori S; Tokoro T; Ikehara S; Kumazawa H; Yamashita T; Nishikawa M; Inada M
Thyroid; 1996 Oct; 6(5):437-43. PubMed ID: 8936668
[TBL] [Abstract][Full Text] [Related]
66. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
[TBL] [Abstract][Full Text] [Related]
67. Immunoglobulin A class fibroblast antibodies in patients with Graves' disease and pretibial myxedema.
Arnold K; Metcalfe R; Weetman AP
J Clin Endocrinol Metab; 1995 Dec; 80(12):3430-7. PubMed ID: 8530579
[TBL] [Abstract][Full Text] [Related]
68. Carbimazole and the autoimmune response in Graves' disease.
McGregor AM; Petersen MM; McLachlan SM; Rooke P; Smith BR; Hall R
N Engl J Med; 1980 Aug; 303(6):302-7. PubMed ID: 6247656
[TBL] [Abstract][Full Text] [Related]
69. IL-2 receptor-positive intrathyroidal lymphocytes in Graves' disease. Analysis of V alpha transcript microheterogeneity.
McIntosh RS; Tandon N; Pickerill AP; Davies R; Barnett D; Weetman AP
J Immunol; 1993 Oct; 151(7):3884-93. PubMed ID: 8376808
[TBL] [Abstract][Full Text] [Related]
70. Thyroid microsomal antigen in Graves' thyroid is not different from that in normal thyroid.
Hamada N; Degroot LJ; Portmann L; Yamakawa J; Noh J; Okamoto Y; Ohno M; Ito K; Morii H
Endocrinol Jpn; 1991 Oct; 38(5):471-8. PubMed ID: 1843266
[TBL] [Abstract][Full Text] [Related]
71. Immunological features of sporadic multinodular goiter.
Corrales JJ; Orfao A; Miralles JM; López-Berges MC; García LC; González M; Mories MT; San Miguel J
Clin Investig; 1993 Jul; 71(7):552-8. PubMed ID: 8374249
[TBL] [Abstract][Full Text] [Related]
72. Adherence of RFD-1 positive dendritic cells to the basal surface of thyroid follicular cells in Graves' disease.
Mölne J; Jansson S; Ericson LE; Nilsson M
Autoimmunity; 1994; 17(1):59-71. PubMed ID: 8025214
[TBL] [Abstract][Full Text] [Related]
73. T-lymphocyte subsets in pregnant women with Graves' disease.
Bizzarro A; Fontana A; De Bellis A; Daponte A; Iacono G; Peluso G
Acta Endocrinol (Copenh); 1987 Feb; 114(2):218-27. PubMed ID: 2950710
[TBL] [Abstract][Full Text] [Related]
74. Lymphocytes in peripheral blood and thyroid tissue in children with Graves' disease.
Iwona BS; Jadwiga SS; Elzbieta K; Leszek S
World J Pediatr; 2008 Nov; 4(4):274-82. PubMed ID: 19104891
[TBL] [Abstract][Full Text] [Related]
75. No restriction of intrathyroidal T cell receptor V alpha families in the thyroid of Graves' disease.
McIntosh RS; Watson PF; Pickerill AP; Davies R; Weetman AP
Clin Exp Immunol; 1993 Jan; 91(1):147-52. PubMed ID: 8419076
[TBL] [Abstract][Full Text] [Related]
76. Incidence of T cell subset imbalance in relatives of Graves' disease patients.
Biassoni P; Ciprandi G; Ferrini S; Chimini G; Canonica GW; Bagnasco M
J Endocrinol Invest; 1984 Apr; 7(2):141-5. PubMed ID: 6609952
[TBL] [Abstract][Full Text] [Related]
77. Immunohistochemical analysis of the retrobulbar tissues in Graves' ophthalmopathy.
Weetman AP; Cohen S; Gatter KC; Fells P; Shine B
Clin Exp Immunol; 1989 Feb; 75(2):222-7. PubMed ID: 2784734
[TBL] [Abstract][Full Text] [Related]
78. The immunoregulatory influence of transforming growth factor beta in thyroid autoimmunity: TGF beta inhibits autoreactivity in Graves' disease.
Widder J; Dorfinger K; Wilfing A; Trieb K; Pirich K; Loebenstein R; Niederle B; Gessl A; Spitzauer S; Grubeck-Loebenstein B
J Autoimmun; 1991 Aug; 4(4):689-701. PubMed ID: 1777015
[TBL] [Abstract][Full Text] [Related]
79. The peripheral blood compartment in patients with Graves' disease: activated T lymphocytes and increased transitional and pre-naive mature B lymphocytes.
Van der Weerd K; Van Hagen PM; Schrijver B; Kwekkeboom DJ; De Herder WW; Ten Broek MR; Postema PT; Van Dongen JJ; Staal FJ; Dik WA
Clin Exp Immunol; 2013 Nov; 174(2):256-64. PubMed ID: 23901889
[TBL] [Abstract][Full Text] [Related]
80. The prevalence of immunological abnormalities in endemic simple goitre.
Grubeck-Loebenstein B; Kassal H; Smyth PP; Krisch K; Waldhäusl W
Acta Endocrinol (Copenh); 1986 Dec; 113(4):508-13. PubMed ID: 2878552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]